Paul Pannozzo, MD
Interventional Pain Medicine · Peoria, AZNPI 1497792097
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,041 of the $10,668 with a category attached, or 84.7%. It is spread thinly across 36 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,221 and has fallen 67.6% since, to $1,043 in 2025.
Across 399 payments — averaging $26.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Vertiflex, Inc.$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Spinefrontier, Inc.$1K
- Abbott$863
- Relievant Medsystems, Inc.$656
- plus $3K from 30 others
Across 3 payments — averaging $8622.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mesoblast, Inc.$26K
What the payments were for
- Travel & lodging$1,59115%
- Food & beverage$9,04185%
- Education$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 77 | $1,882 |
| Vertiflex, Inc. | 26 | $1,693 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 111 | $1,349 |
| Spinefrontier, Inc. | 6 | $1,075 |
| Abbott | 37 | $863 |
| Relievant Medsystems, Inc. | 4 | $656 |
| Nalu Medical, Inc. | 5 | $307 |
| Pfizer | 12 | $257 |
| Daiichi Sankyo Inc. | 10 | $250 |
| Biohaven Pharmaceuticals, Inc. | 13 | $224 |
| Medtronic | 7 | $219 |
| Collegium Pharmaceutical, Inc. | 13 | $194 |
| Vertos Medical, Inc. | 2 | $179 |
| Mesoblast, Inc. | 1 | $178 |
| IBSA Pharma Inc. | 8 | $159 |
| Sentynl Therapeutics, Inc. | 14 | $148 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $133 |
| Curonix LLC | 1 | $98 |
| Radius Health, Inc. | 4 | $85 |
| Amgen(2 entities) | 4 | $78 |
| MDD US Operations, LLC | 4 | $75 |
| Nevro Corp. | 4 | $74 |
| Arbor Pharmaceuticals, Inc. | 5 | $71 |
| Spinal Simplicity, LLC | 3 | $64 |
| Biodelivery Sciences International, Inc. | 4 | $59 |
| Almatica Pharma LLC | 4 | $51 |
| Biotronik NRO, Inc. | 1 | $39 |
| Saluda Medical Americas, Inc. | 1 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| AbbVie(2 entities) | 2 | $33 |
| Redhill Biopharma Inc. | 1 | $19 |
| Avanos Medical | 1 | $18 |
| Zavation Medical Products, LLC | 2 | $18 |
| Shionogi Inc | 1 | $16 |
| USWM, LLC | 1 | $16 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,268
- InSpan$1,050
- SIJFuse$1,050
- FacetFuse$1,050
- NanoFuse$1,050
- Intracept$581
- ETERNA$194
- Ryoncil$178
- Morphabond ER$166
- SPECTRA WAVEWRITER$165
- mild Device Kit$147
- Nalu Neurostimulation System$134
- GENERAL PAIN MANAGEMENT$126
- INTELLIS$118
How this compares
$10,668 in reported general payments places this provider in the 55th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 47 | $46,699 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 777 | $16,159 |
| Fentanyl | 90 | $10,643 |
| LicartDiclofenac Epolamine | 15 | $10,599 |
| Buprenorphine | 58 | $10,187 |
| Hysingla ErHydrocodone Bitartrate | 14 | $8,865 |
| MovantikNaloxegol Oxalate | 15 | $5,419 |
| OxycontinOxycodone Hcl | 15 | $5,313 |
| Gabapentin | 209 | $4,868 |
| Morphine Sulfate ErMorphine Sulfate | 186 | $4,778 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 142 | $4,616 |
| Pregabalin | 157 | $3,720 |
| Tizanidine Hcl | 214 | $2,666 |
| Eszopiclone | 69 | $2,029 |
| Tramadol Hcl | 199 | $1,233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta | $194 | $46,69947 claims |
| IBSA Pharma Inc.Licart | $159 | $10,59915 claims |
| Redhill Biopharma Inc.Movantik | $19 | $5,41915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 64 interventional pain medicine providers in Arizona.
Other interventional pain medicine in Peoria
- Jennifer DaisPeoria$30K
- Toure KnightonPeoria$2K
- Gary FrankPeoria$215
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.